Clinical Trials on Edematous Fibrosclerotic Panniculopathy (EFP) in United States

Total 17 results

Endo Pharmaceuticals

Completed

A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy

Edematous Fibrosclerotic Panniculopathy (EFP)

United States
Endo Pharmaceuticals

Completed

Real World CCH Study in Adult Females With Cellulite

Cellulite | Edematous Fibrosclerotic Panniculopathy (EFP)

United States, Puerto Rico
Endo Pharmaceuticals

Terminated

Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women

Cellulite | Edematous Fibrosclerotic Panniculopathy (EFP)

United States
Endo Pharmaceuticals
DeNova Research; UCSD Dermatology; The Wall Center for Plastic Surgery; Mathew... and other collaborators

Completed

Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite (MOBI)

Cellulite | Edematous Fibrosclerotic Panniculopathy (EFP)

United States
Endo Pharmaceuticals

Completed

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP

Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)

Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)

Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women (RELEASE-2)

Edematous Fibrosclerotic Panniculopathy (Cellulite)

United States
Endo Pharmaceuticals

Completed

CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques

Laxity; Skin | Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks (APHRODITE)

Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Safety and Effectiveness of EN3835 in the Treatment of EFP in Women

Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)

Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Endo Pharmaceuticals

Completed

Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women (RELEASE-1)

Edematous Fibrosclerotic Panniculopathy (Cellulite)

United States
Endo Pharmaceuticals

Completed

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

Laxity; Skin | Cellulite | Edematous Fibrosclerotic Panniculopathy

United States

3

Subscribe